Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: a prospective one-year evaluation

References

• Gallo MF, Lopez LM, Grimes DA, et al. Combination contraceptives: effects on weight. Cochrane Database Syst Rev 2014;1:CD003987
   PubMedGoogle Scholar
• Walters WAW, Lim YL. Haemodynamic changes in women taking oral contraceptives. J Obstet Gynaecol Br Commonw 1970;77:1088–99
   PubMedGoogle Scholar
• Crane MG, Harris JJ. Effect of oestrogens and gestagens on exchangeable sodium. In: Fregly MJ, Fregly MS, eds. Oral contraceptives and high blood pressure. Gainesville (FL): Dolphin Press; 1974:159–69
   Google Scholar
• Oelkers WK. Effects of estrogens and progestogens on the renin aldosterone system and blood pressure. Steroids 1996;61:166–71
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Zanin R, Cannoletta M, et al. Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures. Fertil Steril 2007;88:1603–8
   PubMed Web of Science ®Google Scholar
• Cagnacci A, De Toni A, Caretto S, et al. Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women. Menopause 2006;13:197–201
   PubMed Web of Science ®Google Scholar
• Poehlman ET. Menopause, energy expenditure, and body composition. Acta Obstet Gynecol Scand 2002;81:603–11
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R, Nath A. Metabolic effects of contraceptive steroids. Rev Endocr Metab Disord 2011;12:63–75
   PubMed Web of Science ®Google Scholar
• Fruzzetti F, Bitzer J. Review of clinical experience with estradiol in combined oral contraceptives. Contraception 2010;81:8–15
   PubMed Web of Science ®Google Scholar
• Ruan X, Seeger H, Mueck AO. The pharmacology of dienogest. Maturitas 2012;71:337–44
   PubMed Web of Science ®Google Scholar
• Oettel M, Bervoas-Matin S, Elger W, et al. A 19-norprogestin without 17alfa- ethinyl group: dienogest from a pharmacokinetic point of view. Drugs Today 1995;31:499–516
   Google Scholar
• Zimmerman H, Thebault JJ, Duvauchelle T, et al. Pharmacokinetics of estradiol valerate 2 mg + dienogest 2 mg after single and repeated oral administration in healthy postmenopausal women. Clin Drug Invest 2000;20:123–34
   PubMed Web of Science ®Google Scholar
• Oettel M, Breitbarth E, Elger W, et al. The pharmacological profile of dienogest. Eur J Contacept Reprod Health Care 1999;4:2–13
   Google Scholar
• Sasagawa S, Shimizu Y, Kami H, et al. Dienogest is a selective progesterone agonist in transactivation analysis with potent endometrial activity due to this efficient pharmacokinetic profile. Steroids 2008;73:222–31
   PubMed Web of Science ®Google Scholar
• Mesch VR, Siseles NO, Maidana PN, et al. Androgens in relationship to cardiovascular risk factors in the menopausal transition. Climacteric 2008;11:509–17
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Ciaponi M, Cappagli B, et al. Climacteric modifications in body weight and fat tissue distribution. Climacteric 1999;2:37–44
   PubMedGoogle Scholar
• Brown WJ, Williams L, Ford JH, et al. Identifying the energy gap: magnitude and determinants of 5-year weight gain in midage women. Obes Res 2005;13:1431–41
   PubMedGoogle Scholar
• Lovejoy JC, Champagne CM, De Jonge L, et al. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes 2008;32:949–58
   PubMed Web of Science ®Google Scholar
• Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 2004;23:1430–53
   PubMed Web of Science ®Google Scholar
• Martinoli R, Mohamed EI, Maiolo C, et al. Total body fluid estimation using bioelectrical impedance: a meta-analysis of the data available in the literature. Acta Diabetol 2003;40:S203–6
   PubMed Web of Science ®Google Scholar
• Gudivaka R, Schoeller DA, Kushner RF, Bolt MJ. Single and multifrequency model for bioelectrical impedance analysis of body water compartments. J Appl Physiol 1999;87:1087–96
   PubMed Web of Science ®Google Scholar
• Uras R, Orrù M, Etzi R, et al. Evidence that in healthy young women, a six-cycle treatment with oral contraceptive containing 30 mcg of ethinylestradiol plus 2 mg of chlormadinone acetate reduces fat mass. Contraception 2009;79:117–21
   PubMed Web of Science ®Google Scholar
• Thomas L, Krebs CI. A review of statistical power analysis software, vol. 78. New York: Bulletin of the Ecological Society of America; 1997:128–39
   Google Scholar
• Burger HG, Hale GE, Dennerstein L, Robertson D. Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause 2008;15:603–12
   PubMed Web of Science ®Google Scholar
• Weiss G, Skurnick JH, Goldsmith LT, et al. Menopause and hypothalamic-pituitary sensitivity to estrogen. JAMA 2004;292:2991–6
   PubMed Web of Science ®Google Scholar
• Batrinos ML. Premenopause: the endocrinology of reproduction decline. Hormones 2013;12:334–49
   PubMedGoogle Scholar
• Santoro N, Isaac B, Neal-Perry G, et al. Impaired folliculogenesis and ovulation in older reproductive aged women. J Clin Endocrinol Metab 2003;88:5502–9
   PubMed Web of Science ®Google Scholar
• Burger HG, Dudley EC, Cui J, et al. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000;85:2832–8
   PubMed Web of Science ®Google Scholar
• Abdulnour J, Doucet E, Martin B, et al. The effect of the menopausal transition on body composition and cardiometabolic risk factors: a Montreal-Ottawa New Emerging Team group study. Menopause 2012;19:760–7
   PubMed Web of Science ®Google Scholar
• Grandi G, Piacenti I, Volpe A, Cagnacci A. Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol. Gynecol Endocrinol 2014;30:676–80
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Volpe A, Paoletti AM, Melis GB. Regulation of the 24-hour rhythm of body temperature in menstrual cycles with spontaneous and gonadotropin-induced ovulation. Fertil Steril 1997;68:421–5
   PubMed Web of Science ®Google Scholar
• Stachenfeld NS, Silva C, Keefe DL. Estrogen modifies the temperature effects of progesterone. J Appl Physiol 2000;88:1643–9
   PubMed Web of Science ®Google Scholar
• Endrikat J, Parke S, Trummer D, et al. Pituitary, ovarian and additional contraceptive benefits of an estradiol-based combined oral contraceptive: results of a randomized, open-label, study. Contraception 2013;87:227–34
   PubMed Web of Science ®Google Scholar
• Lopez M, Tena-Sempere M. Estrogens and the control of energy homeostasis: a brain perspective. Trens Endocrinol Metab 2015;26:411–21
   PubMed Web of Science ®Google Scholar
• Wiltgen D, Spritzer PM. Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes. Fertil Steril 2010;94:2493–6
   PubMed Web of Science ®Google Scholar
• Amato MC, Guarnotta V, Giordano C. Body composition assessment for the definition of cardiometabolic risk. J Endocrinol Invest 2013;36:537–43
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Paoletti AM, Arangino S, et al. Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism. Hum Reprod 1999;14:893–7
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Paoletti AM, Renzi A, et al. Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel. J Clin Endocrinol Metab 2003;88:3621–5
   PubMed Web of Science ®Google Scholar
• Zeun S, Lu M, Uddin A, et al. Pharmacokinetics of an oral contraceptive containinbg oestradiol valerate and dienogest. Eur J Contracept Reprod Health Care 2009;14:221–32
   PubMed Web of Science ®Google Scholar
• Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010;316:129–39
   PubMed Web of Science ®Google Scholar
• Macciò A, Madeddu C, Mantovani G. Adipose tissue as target organ in the treatment of hormone-dependent breast cancer: new therapeutic perspectives. Obes Rev 2009;10:660–70
   PubMed Web of Science ®Google Scholar